Virtual Reality for Dose Optimization in Pediatric Nuclear Medicine: Better Than the Real Thing: FIGURE 1.

Zanzonico, Pat

doi:10.2967/jnumed.111.097188

Cited by 8 publications

(6 citation statements)

References 10 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerning pediatric nuclear medicine, the European Association of Nuclear Medicine (EANM) dosage card has been proposed and developed by the Pediatric Task Group EANM in Europe [ 18 – 21 ] and consensus guidelines have been proposed and developed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in North America [ 22 – 26 ]. In 2014, the Japanese consensus guidelines for pediatric nuclear medicine were provided by JSNM in Japan [ 27 ].…”

Section: Introductionmentioning

confidence: 99%

Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan

et al. 2016

View full text Add to dashboard Cite

ObjectiveThe optimization of medical exposure is one of the major issues regarding radiation protection in the world, and The International Committee of Radiological Protection and the International Atomic Energy Agency recommend establishing diagnostic reference levels (DRLs) as tools for dose optimization. Therefore, the development of DRLs based on the latest survey has been required for nuclear medicine-related societies and organizations. This prompted us to conduct a nationwide survey on the actual administered radioactivity to adults for the purpose of developing DRLs in nuclear medicine.MethodsA nationwide survey was conducted from November 25, 2014 to January 16, 2015. The questionnaire was sent to all of the 1249 nuclear medicine facilities in Japan, and the responses were collected on a website using an answered form.ResultsResponses were obtained from 516 facilities, for a response rate of 41 %. 75th percentile of 99mTc-MDP and 99mTc-HMDP: bone scintigraphy, 99mTc-HM-PAO, 99mTc-ECD and 123I-IMP: cerebral blood flow scintigraphy, 99mTc-Tetrofosmin, 99mTc-MIBI and 201Tl-Cl; myocardial perfusion scintigraphy and 18F-FDG: oncology PET (in-house-produced or delivery) in representative diagnostic nuclear medicine scans were 932, 937, 763, 775, 200, 831, 818, 180, 235 and 252, respectively. More than 90 % of the facilities were within the range of 50 % from the median of these survey results in representative diagnostic nuclear medicine facilities in Japan. Responses of the administered radioactivities recommended by the package insert, texts and guidelines such as 740 MBq (99mTc-MDP and 99mTc-HMDP: bone scintigraphy), 740 MBq (99mTc-ECD and 99mTc-HM-PAO: cerebral blood flow scintigraphy) and 740 MBq (99mTc-Tetrofosmin and 99mTc-MIBI: myocardial perfusion scintigraphy), etc. were numerous. The administered activity of many radiopharmaceuticals of bone scintigraphy (99mTc-MDP and 99mTc-HMDP), cerebral blood flow scintigraphy (99mTc-HM-PAO) and myocardial perfusion scintigraphy (99mTc-Tetrofosmin and 99mTc-MIBI), etc. were within the range of the EU DRLs and almost none of the administered radioactivity in Japan exceeded the upper limit of SNMMI standard administered radioactivity.ConclusionsThis survey indicated that the administered radioactivity in diagnostic nuclear medicine in Japan had been in the convergence zone and nuclear medicine facilities in Japan show a strong tendency to adhere to the texts and guidelines. Furthermore, the administered radioactivities in Japan were within the range of variation of the EU and the SNMMI administered radioactivities.

show abstract

Section: Introductionmentioning

confidence: 99%

Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan

et al. 2016

View full text Add to dashboard Cite

show abstract

“…35 People speak regarding another bright advancement commenced by a scientist wherever VR is measured a lot improved substitute to identify tumor related to patients in contrast with conventional scientific observations that engage illustration events by means of potentially injurious emission which might amplify the threat of melanoma. 36 'Ross' (Robotic Surgical Simulator) is a virtual simulator used to train aspiring surgeons and was developed in 2011. This invention alarmed an assembly that incorporated doctors qualified to perform mechanized operations.…”

Section: Virtual Reality -Approach In Cancer Researchmentioning

confidence: 99%

Virtual reality in bioinformatics

Patil¹,

Batra²

2019

OAJS

View full text Add to dashboard Cite

Virtual Reality (VR) is a well-known acknowledged field with many benefits in different sectors. There have also been many applications in entertainment, research, training and medical facilities. When we perform any action there is a similar reaction on real objects according to the nature hence it is a general understanding that we need to simulate the same action-perception relationship virtually without involving real objects or real events. Virtual Reality has a main component called the visualization that occurs by interaction between human and machine bringing it closer to real life. In virtual reality we need to break the barrier amid the real world and the virtual world. For the simulation of the technology one needs to produce an artificial sensation of touch, hear, smell, and feel based on the real one. In this paper we study about the different applications of Virtual Reality in Bioinformatics and also the history of Virtual reality. We take a brief look towards the immersive analytics of virtual reality. The tools used to produce the virtual environment are also being acknowledged with incorporating this knowledge. We also take a look towards the interaction of Virtual reality with many different properties and independent agents. We try to understand what a virtual world is and its uses. We illustrate the usage of Virtual Reality for cancer research and its approaches towards developing better medical therapies. Unfortunately, there are a few limitations that need to be overcome like affordability, unrealistic demonstration, and unawareness also discomfort while using the technology and affects to the eyes if used for a long time etc. It is also a very time consuming and complicated process in the making of the virtual environment. Facts like using normal input technologies like keyboard and mouse aren't very efficient for VR but also use of 3D glasses, tracking devices for movement like gloves and biosensors are very expensive to be bought by each individual.

show abstract

“…The European Association of Nuclear Medicine proposed the standardization of pediatric radiopharmaceutical administered doses in 1990 [2], and published new, more detailed guidelines for calculating doses entitled “Pediatric Dosage Card” in 2007 [3, 4]. The Society of Nuclear Medicine and Molecular Imaging also proposed appropriate radiopharmaceutical administered doses for pediatric nuclear medicine studies in 2010 as part of the project to reduce medical radiation exposure of children called “Image Gently” [5–7]. In 2011, an incident of intentional administration of excessive radioactivity to children in nuclear medicine studies at a hospital in Japan was disclosed.…”

Section: Overview Of the Guidelinesmentioning

confidence: 99%

Japanese consensus guidelines for pediatric nuclear medicine

et al. 2014

View full text Add to dashboard Cite

The Japanese Society of Nuclear Medicine has recently published the consensus guidelines for pediatric nuclear medicine. This article is the English version of the guidelines. Part 1 proposes the dose optimization in pediatric nuclear medicine studies. Part 2 comprehensively discusses imaging techniques for the appropriate conduct of pediatric nuclear medicine procedures, considering the characteristics of imaging in children.

show abstract

Virtual Reality for Dose Optimization in Pediatric Nuclear Medicine: Better Than the Real Thing: FIGURE 1.

Cited by 8 publications

References 10 publications

Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan

Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan

Virtual reality in bioinformatics

Japanese consensus guidelines for pediatric nuclear medicine

Contact Info

Product

Resources

About